Clinical Trials Logo

Blood Glucose clinical trials

View clinical trials related to Blood Glucose.

Filter by:

NCT ID: NCT06458946 Recruiting - Blood Glucose Clinical Trials

Monitoring Postprandial Blood Glucose and Insulin in Fruit Snacks

Start date: May 22, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the postprandial glucose and insulin responses after different fruit snacks compared to confection control in a healthy population

NCT ID: NCT06400836 Completed - Blood Glucose Clinical Trials

Nutrient Timing in Connection to Evening Exercise

Start date: January 10, 2022
Phase: N/A
Study type: Interventional

Physical exercise (PE) significantly influences insulin sensitivity (IS), glucose control and overall metabolic health. While PE effectively enhances IS and glucose regulation, the timing of nutrient intake, before and after exercise, plays a crucial role in modulating its effects. The aim of this study is to evaluate how pre- or post-evening exercise carbohydrate (CHO) ingestion influences glucose metabolism and substrate oxidation (fat/CHO) during exercise and after exercise in athletes during the nocturnal period and the morning after during an oral glucose tolerance test (OGTT).

NCT ID: NCT06398340 Not yet recruiting - Healthy Volunteers Clinical Trials

Identifying Wearable Biomarkers to Monitor Dietary Intake

FoodSense
Start date: May 1, 2024
Phase: N/A
Study type: Interventional

Background: Measuring what people eat is a challenge in nutrition research. Traditional methods, like food diaries, rely on self-reporting of individuals, and suffer from poor accuracy and recall bias. Aims: This project aims to identify physiological biomarkers related to food and energy intake, which may be used to develop an objective tool to estimate individuals' food intake in future. Eating behaviours are accompanied by significant physiological changes such as skin temperature, blood oxygen saturation, pulse rate etc. The investigators intend to investigate whether monitoring these physiological changes can help us estimate eating behaviour, such as meal size, eating speed, and duration of meals. Study design: Ten healthy adults will be invited for two study visits at NIHR Imperial Clinical Research Facility. Each visit will last for approximately 2 hr. They will consume a high- and low-calorie meal designed by nutritional researchers in a randomised order. During eating events, the investigators will track their physiological changes via a bedside monitor and wearable sensors. Blood samples will be taken from participants to measure their glycaemic response. Associations between energy load, glycaemic response, and physiological changes will be investigated. Our findings may promote an accelerated development of a wearable tool for dietary assessment in future.

NCT ID: NCT06382506 Completed - Obesity Clinical Trials

The Effect of Hazelnut Flour on Blood Glucose

Hazelnut
Start date: March 21, 2024
Phase: N/A
Study type: Interventional

One of the factors affecting human health is nutrition. The effects of foods on blood glucose are still under investigation. The Glycemic Index (GI), which is associated with many diseases today, is a value that measures the rate at which carbohydrate-containing foods raise blood glucose. It is thought that the loaves of bread produced will be a product with low GI value and can be consumed by celiacs and diabetics. It is aimed to investigate the effect of adding different amounts of hazelnut flour to bread recipes using gluten-free corn flour on blood glucose.

NCT ID: NCT06288178 Completed - Obesity Clinical Trials

The Effect of Consumption of Bread Types Made From Various Flours on Blood Glucose Fluctuations

Obesity
Start date: December 19, 2022
Phase: N/A
Study type: Interventional

The obesities were aimed at the effect of whole wheat (WWB), buckwheat (BWB), and cornbread (CB) on blood glucose by comparing the glycemic index values with reference bread (RB). Overall, WWB consumption had a positive effect on blood glucose in individuals with obesity, while BWB consumption caused an increase in blood glucose levels.

NCT ID: NCT05976633 Completed - Blood Glucose Clinical Trials

Glycemic Response to Wild Rice and Wild Rice Blends in Humans Study

EFGW
Start date: July 14, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to test the effects of wild rice and wild rice blends compared to other rice on glycemic control and evaluating factors that influence glycemic response to wild rice in healthy individuals. The main questions aim to answer: 1. Is there an effect of wild rice on blends on glycemic control and response? 2. Does cooking wild rice via stovetop or microwave change its glycemic response? 3. Is the wild rice blend product palatable? 4. What is the subjective appetite when consuming the treatment? Participants will: - consent to attend 5 study visits being 2.5 hours each - come to each visit fasted for at least 10-12 hours. - complete a Motivation to Eat VAS following each blood measure

NCT ID: NCT05961475 Completed - Blood Glucose Clinical Trials

Monitoring Postprandial Glycemia in Fruit Snacks

Start date: June 22, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the postprandial glucose and insulin responses after different fruit snack consumption in a healthy population.

NCT ID: NCT05750316 Recruiting - Blood Glucose Clinical Trials

Impact of Consumption of Cowpea Leaves on Blood Glucose

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

Intake of foods high in carbohydrates causes a spike in glucose in the blood. Repeated high blood glucose spikes are associated with an increased risk of diabetes. Polyphenols, which are abundant in vegetables, may influence how the body utilises carbohydrates. Cowpea, also referred to as black-eyed peas (Vigna unguiculata (L.) Walp.) leaves, contain polyphenols and fibre that can help regulate blood glucose. The study will be an acute, single-blind, randomised control trial with a cross-over design involving healthy black participants aged ≥18 years. This clinical trial aims to investigate if consuming cowpea leaves can reduce blood glucose spikes after consuming a meal high in carbohydrates. Participants will be randomised to consume either bread with jam containing freeze-dried cowpea leaves (active intervention) or jam without any freeze-dried powder (control group). Blood glucose will be monitored before the intervention and every 15 minutes after the intervention using a continuous glucose monitor.

NCT ID: NCT05585801 Recruiting - Critical Care Clinical Trials

Continuous Glucose Monitoring in Intensive Care Unit

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

Glucose control in ICU patients is challenging and exerts high burden on the nursing staff. Continuous glucose monitors (CGM) are now approved and widely available in the outpatient setting for patients with diabetes mellitus. However, only minimal evidence on CGM performance, reliability and benefit in achieving desired glucose control in the intensive care setting has been gathered so far. The objective of this study is to assess whether the use of CGM helps to maintain blood glucose levels within the time in range recommended for patients in the intensive care. In addition, accuracy of the sensor will be evaluated and compared to measurements of blood glucose by standardized biochemistry methods.

NCT ID: NCT05573607 Completed - Blood Glucose Clinical Trials

Effects of a Dietary Supplement on Markers of Glucose Control and Quality of Life

Start date: November 19, 2020
Phase: N/A
Study type: Interventional

This study is a double-blind, randomized, two-arm, placebo-controlled trial of apparently healthy men and women to be recruited at a single investigational center in Northeast Ohio (i.e. The Center for Applied Health Sciences). Subjects will attend four study visits. During Visit 1, subjects will be screened for participation (i.e., medical history, physical exam, routine blood work [also HgA1c, insulin], background baseline diet). Over the next 12 weeks, subjects will attend Visits 2-4, wherein assessments of serum glucose, insulin, HOMA-IR, 2-hour glucose tolerance test (GTT), HgA1c, C-reactive protein, adiponectin, ferritin, waist circumference, quality of life questionnaire, and various visual analog scales for appetite, satiety, and cravings will be made.